|
PREGABALIN
|
|
|
|
ANTICONVULSANTS MISCELLANEOUS
|
|
Peripheral and central neuropathic pain, adjunctive therapy for focal seizures with or without secondary generalization.
|
|
Dry mouth, constipation, vomiting, flatulence, oedema, dizziness, drowsiness, irritability, impaired attention, disturbances in muscle control and movement, speech disorder, impaired memory .
|
|
Adult: Neuropathic pain: Initially 150 mg daily in 2-3 divided doses. Maximum dose 600mg daily in divided doses. Epilepsy:
150 mg daily increased after 1 week according to response 300 mg daily in 2-3 divided doses. Maximum dose 600mg daily in divided dos |
|
|
|
|
|
|
|
|